In general, downregulation of PARP1 could modulate many factors in the cell life cycle and cell death to suppress proliferation of carcinomas, which has been demonstrated in PARP−/− mice models and human breast cancer cells, and so on [49,60]. Here, PARP1 is linked to breast carcinoma.